Weiming Luo

机构：Nanchang University, Xuzhou Medical College, Second Affiliated Hospital of Nanchang University, National Institute on Aging, Delft University of Technology · ORCID：0009-0002-3035-3176

发表论文 67 篇 · 总被引 2245 次 · h-index 22

代表论文

• Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis (2022 · Alzheimer s & Dementia · 被引 218)
• 3,6’-dithiopomalidomide reduces neural loss, inflammation, behavioral deficits in brain injury and microglial activation (2020 · eLife · 被引 39)
• Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide Analogs (2020 · Molecules · 被引 23)
• Experimental study on the integrated thermal management system based on composite phase change materials coupled with metal heating film (2022 · Applied Thermal Engineering · 被引 22)
• N -Adamantyl Phthalimidine: A New Thalidomide-like Drug That Lacks Cereblon Binding and Mitigates Neuronal and Synaptic Loss, Neuroinflammation, and Behavioral Deficits in Traumatic Brain Injury and LPS Challenge (2021 · ACS Pharmacology & Translational Science · 被引 22)
• 3,6′-Dithiopomalidomide Ameliorates Hippocampal Neurodegeneration, Microgliosis and Astrogliosis and Improves Cognitive Behaviors in Rats with a Moderate Traumatic Brain Injury (2021 · International Journal of Molecular Sciences · 被引 18)